| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 08/03/2004 | CA2041093C A pharmacological composition containing polyelectrolyte complexes in microparticulate form and at least one active substance |
| 07/29/2004 | WO2004063330A2 (2-carboxamido) (3-amino) thiophene compounds |
| 07/29/2004 | WO2004063146A1 Hydroxamic acid derivatives having anti-inflammatory action |
| 07/29/2004 | WO2004062729A1 Pharmaceutical combination for the prophylaxis or treatment of cardiovascular, cardiopulmonary, pulmonary or renal diseases |
| 07/29/2004 | WO2004062691A1 Agent improving proton-driven transporter-mediated absorption in digestive tract and process for producing the same |
| 07/29/2004 | WO2004062680A1 Attaining sexual wellness and health of the sexual vascular system with proanthocyanidins |
| 07/29/2004 | WO2004062676A1 -modified nucleoside derivatives for treating flaviviridae infections |
| 07/29/2004 | WO2004062672A1 Multivitamin regimen for renal patients |
| 07/29/2004 | WO2004062671A2 Pde4 inhibitors for the treatment of neoplasms of lymphoid cells |
| 07/29/2004 | WO2004062660A1 Contact lens and eye drop rewetter compositions and their uses |
| 07/29/2004 | WO2004062659A1 Methods and compositions for preventing/reducing the severity of side effects of chemotherapy and/or radiotherapy |
| 07/29/2004 | WO2004062656A1 Compositions and methods for improving the condition of patients suffering from copd and other diseases |
| 07/29/2004 | WO2004062654A1 Use of cyclin d1 inhibitors |
| 07/29/2004 | WO2004062652A1 Prevention and treatment of alzheimer's disease |
| 07/29/2004 | WO2004062626A2 Composition and method for treating age-related disorders |
| 07/29/2004 | WO2004062624A2 Method of treating nausea, vomiting, retching or any combination thereof |
| 07/29/2004 | WO2004062623A2 Method of treating functional bowel disorders |
| 07/29/2004 | WO2004062614A2 Carbohydrate conjugates to prevent abuse of controlled substances |
| 07/29/2004 | WO2004062604A2 Treatment of cancer with 2-deoxyglucose |
| 07/29/2004 | WO2004062580A2 Odorless formulation for treating mucosal discontinuities |
| 07/29/2004 | WO2004052349A3 Compositions comprising a combination of diphenyl ura impdh inhibitors and apoptosis-inducing anti-cancer agents |
| 07/29/2004 | WO2004047866A3 Use of the corticoliberin-urocortin system in the treatment of inflammatory diseases |
| 07/29/2004 | WO2004045533A3 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 07/29/2004 | WO2004041162A3 Inhibitors of akt activity |
| 07/29/2004 | WO2004037233A3 Use of glycogen phosphorylase inhibitors for treatment of cardiovascular diseases |
| 07/29/2004 | WO2004037173A3 Method for treating erectile dysfunction and increasing libido in men |
| 07/29/2004 | WO2004032873A3 Therapeutic combination of carnitine and antioxidant polyphenols |
| 07/29/2004 | WO2004031401A3 Novel tyrosine kinases inhibitors |
| 07/29/2004 | WO2004020631A3 Genetic suppression and replacement |
| 07/29/2004 | WO2004010972A3 Pellicle-resistant gelatin capsule |
| 07/29/2004 | WO2003092621A3 Composition and method for dermatological treatment |
| 07/29/2004 | WO2003075741A3 METHODS OF PREVENTING OR TREATING DISORDERS BY ADMINISTERING AN INTEGRIN αvβ3 ANTAGONIST IN COMBINATION WITH AN HMG-CoA REDUCTASE INHIBITOR OR A BISPHOSPHONATE |
| 07/29/2004 | WO2003068803A3 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof |
| 07/29/2004 | WO2003059951A8 Novel anti-igf-ir antibodies and uses thereof |
| 07/29/2004 | WO2003059355A8 Quinazolinone compounds in combined modalities for improved cancer treatment |
| 07/29/2004 | WO2003040107A8 Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity |
| 07/29/2004 | WO2003028634A8 Method of treatment using ligand-immunogen conjugates |
| 07/29/2004 | WO2003025150A3 Lipid-associated molecules |
| 07/29/2004 | WO2003022123A3 Methods of kidney transplantation utilizing developing nephric tissue |
| 07/29/2004 | US20040147904 Methods and devices for delivery of agents to breast milk ducts |
| 07/29/2004 | US20040147745 Novel compounds and compositions as protease inhibitors |
| 07/29/2004 | US20040147739 Novel anti-infectives |
| 07/29/2004 | US20040147724 for diagnosis/treatment of cancer, myeloproliferative disorders, angiogenesis, obesity, osteoporosis, non-insulin dependent diabetes, lipid metabolism disorder, hypercalcemia, hypercholestrolemia; genetic engineering |
| 07/29/2004 | US20040147614 Serotonin receptor antagonist; administering reboxetine; psychological disorders |
| 07/29/2004 | US20040147613 Synergistic mixture; blocking neurotransmitters; dopamine receptors; haloperidol and (meth)amphetamine |
| 07/29/2004 | US20040147609 Liquid drug preparations |
| 07/29/2004 | US20040147599 Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors |
| 07/29/2004 | US20040147596 Antidiabetic agents; immunology diseases; antiinflammatory agents |
| 07/29/2004 | US20040147595 Biofilm degrading or sloughing compositions and methods |
| 07/29/2004 | US20040147585 Bis(indol-3-yl)acetic acid ,or ester thereof; drug or cosmetic |
| 07/29/2004 | US20040147582 Use of etodolac for the treatment of chronic lymphocytic leukemia |
| 07/29/2004 | US20040147581 Method of using a Cox-2 inhibitor and a 5-HT1A receptor modulator as a combination therapy |
| 07/29/2004 | US20040147566 Lisinopril/lercanidipine combination therapy |
| 07/29/2004 | US20040147564 Combinations of glimepiride and the thiazolidinedione for treatment of diabetes |
| 07/29/2004 | US20040147562 Controlling cell gene expression; moderate cell proliferation; anticancer agents; antiinflammatory agents; cardiovascular disorders; autoimmune disease |
| 07/29/2004 | US20040147549 Antiviral compounds |
| 07/29/2004 | US20040147544 Pde4 inhibitor and an anti-cholinergic agent in combination for treating obstructive airways diseases |
| 07/29/2004 | US20040147541 Using rapamycin; antitumor agents; angiogenesis inhibitors |
| 07/29/2004 | US20040147540 Compositions and methods for inhibiting platelet activation and thrombosis |
| 07/29/2004 | US20040147534 Topical composition and method for treating occlusive wounds |
| 07/29/2004 | US20040147510 Administering serotonine receptor antagonist and adrenaline reuptake inhibitor |
| 07/29/2004 | US20040147509 Method of treating functional bowel disorders |
| 07/29/2004 | US20040147488 Method of modifying the release profile of sustained release compositions |
| 07/29/2004 | US20040147478 Administering to the patient a combination of a therapeutically effective amount of a MEK inhibitor and a therapeutically effective amount of capecitabine |
| 07/29/2004 | US20040147473 Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomers |
| 07/29/2004 | US20040147468 Immunostimulatory nucleic acid molecules |
| 07/29/2004 | US20040147459 Administering a dosage of one to two teaspoons of D-mannose to the patient three times a day with meals for one to two weeks or until the symptoms subside |
| 07/29/2004 | US20040147457 Mixtures of fructose and lactose as a low-calorie bulk sweetener with reduced glycemic index |
| 07/29/2004 | US20040147456 For therapy and prophylaxis of thrombolytic condition |
| 07/29/2004 | US20040147449 For inhibition of vascularization and for cancer therapy |
| 07/29/2004 | US20040147445 For therapy and prophylaxis of arthritis and other inflammatory and autoimmune diseases |
| 07/29/2004 | US20040146981 DNA encoding human serine protease D-G |
| 07/29/2004 | US20040146964 Assays, methods and means |
| 07/29/2004 | US20040146951 from pancreas cells; for drug screening compounds that also bind to somatostatin type-5 receptor ("SSTR-5") |
| 07/29/2004 | US20040146946 used to study oxidative stress-related disorders and diseases and drug screening treatments for Alzheimer's disease |
| 07/29/2004 | US20040146945 used to study oxidative stress-related disorders and diseases and drug screening treatments for Alzheimer's disease |
| 07/29/2004 | US20040146933 Latent human tuberculosis model, diagnostic antigens, and methods of use |
| 07/29/2004 | US20040146929 for drug screening, in vitro or in vivo diagnosis, and gene therapy; antitumor agents; genetic engineering; kits |
| 07/29/2004 | US20040146882 Human acid sensing ion channel 2b (hASIC2b), process for producing the same, and its use |
| 07/29/2004 | US20040146872 Comprises nucleotide sequences coding delta-2-enoyl-coA isomerase for use in identifying modulators for treatment and diagnosis of inflammatory, cardiovascular, skin, body weight and cancer disorders |
| 07/29/2004 | US20040146853 Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
| 07/29/2004 | US20040146595 Breast cancer ; therapy containing plant extracts |
| 07/29/2004 | US20040146585 Side effect reduction of cancer therapy; using sodium thiosulfate |
| 07/29/2004 | US20040146532 Agents and methods for treating pain |
| 07/29/2004 | US20040146498 3-(2,3-Dihydroxycyclopentyl)-6-alkylthio-8-cyclopropylamino-3H-v-triazolo[4,5-d]pyrimidine derivatives as anticoagulants |
| 07/29/2004 | US20040146495 Analyzing a blood sample for secretin level |
| 07/29/2004 | US20040146469 Dermal penetration enhancers and drug delivery systems involving same |
| 07/29/2004 | US20040146459 Renal nuclear matrix proteins, polynucleotide sequences encoding them, and their use |
| 07/29/2004 | DE10301930A1 Treatment and prevention of disease by combined enteral and parenteral administration, useful specifically for protection against poisoning by cholinesterase inhibitors |
| 07/29/2004 | DE10301372A1 Combined administration of simvastatin and telmisartan, useful for treating cardiovascular, pulmonary and renal diseases, also hypertension and hyperlipemia |
| 07/29/2004 | CA2513399A1 Treatment of cancer with 2-deoxyglucose |
| 07/29/2004 | CA2513219A1 Multivitamin regimen for renal patients |
| 07/29/2004 | CA2513129A1 Attaining sexual wellness and health of the sexual vascular system with proanthocyanidins |
| 07/29/2004 | CA2512983A1 Method of treating functional bowel disorders |
| 07/29/2004 | CA2512951A1 Carbohydrate conjugates to prevent abuse of controlled substances |
| 07/29/2004 | CA2512819A1 Pde4 inhibitors for the treatment of neoplasms of lymphoid cells |
| 07/29/2004 | CA2512345A1 Odorless formulation for treating mucosal discontinuities |
| 07/29/2004 | CA2512320A1 Contact lens and eye drop rewetter compositions and their uses |
| 07/29/2004 | CA2512022A1 Method of treating nausea, vomiting, retching or any combination thereof |
| 07/29/2004 | CA2507945A1 Prevention and treatment of alzheimer's disease |